Welcome to this week’s newsletter from Zimmer and Peacock. This newsletter is a mixture of news, stories and tech notes from Zimmer and Peacock. If you want to subscribe to our newsletter or have any questions regarding Zimmer and Peacock and our passion for biosensor technologies please don’t hesitate to contact us.
Commercial Microneedle Arrays
At ZP we know that part of the future of wellbeing and health is continuous monitoring of biochemical markers, including: lactate, glucose, potassium, sodium etc.
ZP’s technology suitable for Sepsis detection
Many clinicians and care providers are calling for the early detection of sepsis, and though there is a body of work focusing on the interleukins, including IL6, there is a primary signal for sepsis which is the bacteria itself, this includes: Streptococcus pneumoniae, Neisseria meningitidis, and Staphylococcus aureus.
The ZP screen printed electrode platform and our ability to detect whole cells is a great platform for Sepsis detection, either through proteins such as the interleukins or the pathogens directly.
To find out more please don’t hesitate to contact us.
